Blackhill Capital’s Celgene Corp CELG Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2019
Q4 | – | Sell |
-28,000
| Closed | -$2.78M | – | 68 |
|
|
2019
Q3 | $2.78M | Hold |
28,000
| – | – | 0.44% | 28 |
|
|
2019
Q2 | $2.59M | Hold |
28,000
| – | – | 0.42% | 29 |
|
|
2019
Q1 | $2.64M | Hold |
28,000
| – | – | 0.45% | 29 |
|
|
2018
Q4 | $1.79M | Buy |
28,000
+3,200
| +13% | +$236K | 0.34% | 31 |
|
|
2018
Q3 | $2.22M | Hold |
24,800
| – | – | 0.36% | 28 |
|
|
2018
Q2 | $1.97M | Hold |
24,800
| – | – | 0.35% | 30 |
|
|
2018
Q1 | $2.21M | Hold |
24,800
| – | – | 0.41% | 29 |
|
|
2017
Q4 | $2.59M | Hold |
24,800
| – | – | 0.47% | 28 |
|
|
2017
Q3 | $3.62M | Hold |
24,800
| – | – | 0.68% | 25 |
|
|
2017
Q2 | $3.22M | Hold |
24,800
| – | – | 0.62% | 25 |
|
|
2017
Q1 | $3.09M | Hold |
24,800
| – | – | 0.57% | 26 |
|
|
2016
Q4 | $2.87M | Hold |
24,800
| – | – | 0.54% | 26 |
|
|
2016
Q3 | $2.59M | Hold |
24,800
| – | – | 0.43% | 28 |
|
|
2016
Q2 | $2.45M | Hold |
24,800
| – | – | 0.4% | 28 |
|
|
2016
Q1 | $2.48M | Hold |
24,800
| – | – | 0.41% | 28 |
|
|
2015
Q4 | $2.97M | Hold |
24,800
| – | – | 0.46% | 28 |
|
|
2015
Q3 | $2.68M | Hold |
24,800
| – | – | 0.36% | 30 |
|
|
2015
Q2 | $2.87M | Hold |
24,800
| – | – | 0.35% | 31 |
|
|
2015
Q1 | $2.86M | Hold |
24,800
| – | – | 0.35% | 32 |
|
|
2014
Q4 | $2.77M | Hold |
24,800
| – | – | 0.35% | 32 |
|
|
2014
Q3 | $2.35M | Hold |
24,800
| – | – | 0.32% | 37 |
|
|
2014
Q2 | $2.13M | Hold |
24,800
| – | – | 0.29% | 39 |
|
|
2014
Q1 | $1.73M | Hold |
24,800
| – | – | 0.25% | 38 |
|
|
2013
Q4 | $2.1M | Hold |
24,800
| – | – | 0.32% | 37 |
|
|
2013
Q3 | $1.91M | Hold |
24,800
| – | – | 0.31% | 39 |
|
|
2013
Q2 | $1.45M | Buy |
+24,800
| New | +$1.49M | 0.24% | 41 |
|
Other funds holding CELG
FP
HCM
PCMC
WCG
Blackhill Capital's CELG Position: Q4 2019 in Review
Blackhill Capital sold out of Celgene Corp (CELG) in Q4 2019, closing a stake of 28,000 shares — an estimated $2.78M sold.
Blackhill Capital first reported a position in CELG in Q2 2013 and held it in 26 quarters. The position peaked at $3.62M in Q3 2017. 4 funds tracked by Wall St. Rank hold CELG as of Q4 2019.
- Blackhill Capital reported no remaining Celgene Corp position as of Q4 2019 after selling out during the quarter.
- Blackhill Capital sold 28,000 Celgene Corp shares in Q4 2019, an estimated $2.78M.
- Blackhill Capital first reported a position in Celgene Corp in Q2 2013 and held it in 26 quarters.
- Blackhill Capital's Celgene Corp position peaked at $3.62M in Q3 2017.
- 4 funds tracked by Wall St. Rank held Celgene Corp as of Q4 2019.
Based on Blackhill Capital's 13F filing for Q4 2019, filed 10 Feb 2020.